NCT00810966: ABT-888 and Cyclophosphamide in Treating Patients With Solid Tumors or Lymphoma That Did Not Respond to Previous Therapy |
|
|
| Active, not recruiting | 1 | 50 | US | cyclophosphamide, veliparib, immunologic technique, laboratory biomarker analysis, liquid chromatography, mass spectrometry, pharmacological study | National Cancer Institute (NCI) | Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | | | | |
NCT00960050: Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
|
|
| Active, not recruiting | 1 | 173 | US | polymorphism analysis, laboratory biomarker analysis, medical chart review, assessment of therapy complications | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm | 05/15 | | | |
